Document is current
Any future updates will be listed below
-
Authors
Klapp, Vanessa
Buqué, Aitziber
Bloy, Norma
Sato, Ai
Yamazaki, Takahiro
Zhou, Xi Kathy
Formenti, Silvia C.
Galluzzi, Lorenzo
Petroni, Giulia https://orcid.org/0000-0002-0558-5322
- License Information
-
More Information
Article History
Received: 2 January 2023
Accepted: 2 February 2023
First Online: 10 February 2023
Declarations
:
: All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Weill Cornell Medical College (#2017–0012, #2019–0022).
: Not applicable.
: SCF has been holding research contracts with Merck, Varian, Bristol Myers Squibb, Celldex, Regeneron, Eisai, and Eli-Lilly, and has received consulting/advisory honoraria from Bayer, Bristol Myers Squibb, Varian, Elekta, Regeneron, Eisai, AstraZeneca, MedImmune, Merck US, EMD Serono, Accuray, Boehringer Ingelheim, Roche, Genentech, AstraZeneca, View Ray and Nanobiotix. LG is or has been holding research contracts with Lytix Biopharma, Promontory and Onxeo, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation, and holds Promontory stock options.
